Sam Brusco, Associate Editor02.08.24
Exactech began an exclusive partnership with medical device developer Statera Medical to design the world’s first smart reverse shoulder implant.
Their project kickoff meeting took place in January 2024 and they will collaborate over the next few years to co-develop the new implant.
Statera’s CEO Samuel Bordon said the company developed the Goldilocks smart implant technology to help treat patients with more precision. Smart implants provide more objective data, which aims to help surgeons choose the correct implant size and offset for a patient, as well as offer the best balance of joint mobility and stability for all major joints.
Our breakthrough device-designated technology provides real-time data and adjustment capability to help surgeons uniquely treat their patients,” Bordon said. “We are excited to partner with Exactech to exclusively integrate this transformative technology into the Equinoxe platform shoulder system."
Exactech’s senior VP of extremities Chris Roche added that the current process surgeons use to select reverse shoulder implant size and offset is subjective. If the reconstructed joint is loose, the patient can risk instability. If it’s too tight, the patient can risk scapular stress fractures and implant loosening.
In partnership with Statera, we will create a new process to help surgeons objectively quantify a patient's soft tissue tension and then adjust the ideal implant offset and size for that particular patient," Roche said. "Exactech has long been a leader in shoulder arthroplasty research as well as development of artificial intelligence-based clinical software. The application of Statera's novel smart implant technology will provide valuable new data that will help surgeons and researchers better understand reverse shoulder biomechanics, ultimately leading to better treatment for patients."
Their project kickoff meeting took place in January 2024 and they will collaborate over the next few years to co-develop the new implant.
Statera’s CEO Samuel Bordon said the company developed the Goldilocks smart implant technology to help treat patients with more precision. Smart implants provide more objective data, which aims to help surgeons choose the correct implant size and offset for a patient, as well as offer the best balance of joint mobility and stability for all major joints.
Our breakthrough device-designated technology provides real-time data and adjustment capability to help surgeons uniquely treat their patients,” Bordon said. “We are excited to partner with Exactech to exclusively integrate this transformative technology into the Equinoxe platform shoulder system."
Exactech’s senior VP of extremities Chris Roche added that the current process surgeons use to select reverse shoulder implant size and offset is subjective. If the reconstructed joint is loose, the patient can risk instability. If it’s too tight, the patient can risk scapular stress fractures and implant loosening.
In partnership with Statera, we will create a new process to help surgeons objectively quantify a patient's soft tissue tension and then adjust the ideal implant offset and size for that particular patient," Roche said. "Exactech has long been a leader in shoulder arthroplasty research as well as development of artificial intelligence-based clinical software. The application of Statera's novel smart implant technology will provide valuable new data that will help surgeons and researchers better understand reverse shoulder biomechanics, ultimately leading to better treatment for patients."